Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 139

Similar articles for PubMed (Select 20817093)

1.

Functional rescue of excitatory synaptic transmission in the developing hippocampus in Fmr1-KO mouse.

Meredith RM, de Jong R, Mansvelder HD.

Neurobiol Dis. 2011 Jan;41(1):104-10. doi: 10.1016/j.nbd.2010.08.026. Epub 2010 Sep 15.

PMID:
20817093
2.
3.
4.

Rescue of behavioral phenotype and neuronal protrusion morphology in Fmr1 KO mice.

de Vrij FM, Levenga J, van der Linde HC, Koekkoek SK, De Zeeuw CI, Nelson DL, Oostra BA, Willemsen R.

Neurobiol Dis. 2008 Jul;31(1):127-32. doi: 10.1016/j.nbd.2008.04.002. Epub 2008 Apr 25.

5.

Pharmacological reversal of synaptic plasticity deficits in the mouse model of fragile X syndrome by group II mGluR antagonist or lithium treatment.

Choi CH, Schoenfeld BP, Bell AJ, Hinchey P, Kollaros M, Gertner MJ, Woo NH, Tranfaglia MR, Bear MF, Zukin RS, McDonald TV, Jongens TA, McBride SM.

Brain Res. 2011 Mar 22;1380:106-19. doi: 10.1016/j.brainres.2010.11.032. Epub 2010 Nov 12.

6.

Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP.

Yan QJ, Rammal M, Tranfaglia M, Bauchwitz RP.

Neuropharmacology. 2005 Dec;49(7):1053-66. Epub 2005 Jul 27.

PMID:
16054174
7.

Activation of 5-HT7 serotonin receptors reverses metabotropic glutamate receptor-mediated synaptic plasticity in wild-type and Fmr1 knockout mice, a model of Fragile X syndrome.

Costa L, Spatuzza M, D'Antoni S, Bonaccorso CM, Trovato C, Musumeci SA, Leopoldo M, Lacivita E, Catania MV, Ciranna L.

Biol Psychiatry. 2012 Dec 1;72(11):924-33. doi: 10.1016/j.biopsych.2012.06.008. Epub 2012 Jul 18.

PMID:
22817866
8.

Altered hippocampal synaptic plasticity in the FMR1 gene family knockout mouse models.

Zhang J, Hou L, Klann E, Nelson DL.

J Neurophysiol. 2009 May;101(5):2572-80. doi: 10.1152/jn.90558.2008. Epub 2009 Feb 25.

9.

Group I metabotropic glutamate receptor antagonists alter select behaviors in a mouse model for fragile X syndrome.

Thomas AM, Bui N, Perkins JR, Yuva-Paylor LA, Paylor R.

Psychopharmacology (Berl). 2012 Jan;219(1):47-58. doi: 10.1007/s00213-011-2375-4. Epub 2011 Jun 10.

PMID:
21656124
10.

Chronic administration of AFQ056/Mavoglurant restores social behaviour in Fmr1 knockout mice.

Gantois I, Pop AS, de Esch CE, Buijsen RA, Pooters T, Gomez-Mancilla B, Gasparini F, Oostra BA, D'Hooge R, Willemsen R.

Behav Brain Res. 2013 Feb 15;239:72-9. doi: 10.1016/j.bbr.2012.10.059. Epub 2012 Nov 6.

PMID:
23142366
11.

Delayed stabilization of dendritic spines in fragile X mice.

Cruz-Martín A, Crespo M, Portera-Cailliau C.

J Neurosci. 2010 Jun 9;30(23):7793-803. doi: 10.1523/JNEUROSCI.0577-10.2010.

12.

Biomedical research. A fix for fragile X syndrome?

Miller G.

Science. 2006 Apr 28;312(5773):521. No abstract available.

PMID:
16645065
13.

Subchronic administration and combination metabotropic glutamate and GABAB receptor drug therapy in fragile X syndrome.

Pacey LK, Tharmalingam S, Hampson DR.

J Pharmacol Exp Ther. 2011 Sep;338(3):897-905. doi: 10.1124/jpet.111.183327. Epub 2011 Jun 2.

14.

Fragile X mental retardation protein regulates heterosynaptic plasticity in the hippocampus.

Connor SA, Hoeffer CA, Klann E, Nguyen PV.

Learn Mem. 2011 Mar 23;18(4):207-20. doi: 10.1101/lm.2043811. Print 2011.

15.

Hypersensitivity to mGluR5 and ERK1/2 leads to excessive protein synthesis in the hippocampus of a mouse model of fragile X syndrome.

Osterweil EK, Krueger DD, Reinhold K, Bear MF.

J Neurosci. 2010 Nov 17;30(46):15616-27. doi: 10.1523/JNEUROSCI.3888-10.2010.

16.

Early continuous inhibition of group 1 mGlu signaling partially rescues dendritic spine abnormalities in the Fmr1 knockout mouse model for fragile X syndrome.

Su T, Fan HX, Jiang T, Sun WW, Den WY, Gao MM, Chen SQ, Zhao QH, Yi YH.

Psychopharmacology (Berl). 2011 May;215(2):291-300. doi: 10.1007/s00213-010-2130-2. Epub 2010 Dec 23.

PMID:
21181121
17.

Group I mGluR antagonist rescues the deficit of D1-induced LTP in a mouse model of fragile X syndrome.

Xu ZH, Yang Q, Feng B, Liu SB, Zhang N, Xing JH, Li XQ, Wu YM, Gao GD, Zhao MG.

Mol Neurodegener. 2012 May 28;7:24. doi: 10.1186/1750-1326-7-24.

19.

Characterization and reversal of synaptic defects in the amygdala in a mouse model of fragile X syndrome.

Suvrathan A, Hoeffer CA, Wong H, Klann E, Chattarji S.

Proc Natl Acad Sci U S A. 2010 Jun 22;107(25):11591-6. doi: 10.1073/pnas.1002262107. Epub 2010 Jun 7.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk